These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 18684536)

  • 1. Correlation between cognitive impairment and left ventricular diastolic dysfunction in patients with cardiovascular diseases.
    Suwa M; Ito T
    Int J Cardiol; 2009 Aug; 136(3):351-4. PubMed ID: 18684536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
    Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure.
    Parekh N; Maisel AS
    Curr Opin Cardiol; 2009 Mar; 24(2):155-60. PubMed ID: 19532102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension.
    Rostoker G; Griuncelli M; Loridon C; Benmaadi A; Illouz E
    Cardiology; 2009; 114(2):142-9. PubMed ID: 19521079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of diagnosis of ischaemic heart disease, diabetes mellitus and heart failure with cognitive function in the elderly population.
    Halling A; Berglund J
    Eur J Gen Pract; 2006; 12(3):114-9. PubMed ID: 17002959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure.
    Feola M; Rosso GL; Peano M; Agostini M; Aspromonte N; Carena G; Salvatico L; Valle R
    Arch Med Res; 2007 Feb; 38(2):234-9. PubMed ID: 17227734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach.
    Ribeiro AL; Teixeira MM; Reis AM; Talvani A; Perez AA; Barros MV; Rocha MO
    Int J Cardiol; 2006 Apr; 109(1):34-40. PubMed ID: 16023747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction.
    Plewka M; Krzemińska-Pakuła M; Lipiec P; Peruga JZ; Jezewski T; Kidawa M; Wierzbowska-Drabik K; Korycka A; Robak T; Kasprzak JD
    Am J Cardiol; 2009 Nov; 104(10):1336-42. PubMed ID: 19892047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired left ventricular synchronicity in patients with metabolic syndrome, regardless of hypertension.
    Li SH; Yang B; Gong HP; Tan HW; Zhong M; Zhang Y; Zhang W
    J Hypertens; 2009 Apr; 27(4):869-75. PubMed ID: 19516184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
    G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of left ventricular dyssynchrony by two-dimensional speckle tracking versus tissue Doppler imaging in patients with non-ST-elevation myocardial infarction and preserved left ventricular systolic function.
    Ng AC; Tran da T; Newman M; Allman C; Vidaic J; Leung DY
    Am J Cardiol; 2008 Nov; 102(9):1146-50. PubMed ID: 18940281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.